A lung cancer drug developed by Akeso Inc. extended patients’ lives by about four months in a late-stage trial in China, ...

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for ...

Pancreatic cancer kills roughly 80% of patients within a year of diagnosis. For those whose tumors have already spread and ...

Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy ...

A new DNA test could help screen whether patients require the treatment or not, according to a new international trial.

Massachusetts General Hospital's SMART program helps other deal with what comes after their cancer diagnosis.

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

Millions of people with breast cancer could safely avoid chemotherapy as scientists have developed a groundbreaking DNA test.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...